In prostate cancer, epigenetic silencing of the crucial component JAK1 kinase of the IFNγ signaling pathway led to IFNγ-insensitivity-mediated tumor evasion and resistance to immunotherapy [110]. This evidence concerns the gene IFNG and Familial prostate cancer.